TotalMarketCap

BioStem Technologies

BSEMNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$46.120 M

$2.47 -10.35%

Close of 7 Oct 2026

As of 7 Oct 2026, BioStem Technologies (BSEM) has a market capitalization of $46.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$47.5M

#2745 by revenue

Earnings

-$6.58M

Loss-making

Shares outstanding

17,849,471

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →
  1. #128Cel SciCVM$48.2M
  2. #129Instil BioTIL$46.7M
  3. #130BioStem TechnologiesBSEM$46.1M
  4. #131TevogenTVGN$42.3M
  5. #132Metagenomi TherapeuticsMGX$38.9M

What if BioStem Technologies were worth as much as…

Open the what-if tool →

Gold $28.8T

$1,541,840

Per share 624,227× higher

Bitcoin $1.67T

$89,451.40

Per share 36,215× higher

Nvidia $5.77T

$308,785.63

Per share 125,014× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for BioStem Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.